By Associate Professor Rebecca McKetin

Journal articles

Acheson LS; Williams BH; Farrell M; McKetin R; Ezard N; Siefried KJ, 2022, 'Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta-analysis of randomised controlled trials', Drug and Alcohol Review, 42, http://dx.doi.org/10.1111/dar.13511

Lee WC; Fang SC; Chen YY; Liu HC; Huang MC; McKetin R, 2021, 'Exploring the mediating role of methamphetamine use in the relationship between adverse childhood experiences and attempted suicide', Addictive Behaviors, 123, http://dx.doi.org/10.1016/j.addbeh.2021.107060

Quinn B; Ward B; Agius PA; Jenkinson R; Hickman M; Sutton K; Hall C; McKetin R; Farrell M; Cossar R; Dietze PM, 2021, 'A prospective cohort of people who use methamphetamine in Melbourne and non-metropolitan Victoria, Australia: Baseline characteristics and correlates of methamphetamine dependence', Drug and Alcohol Review, 40, pp. 1239 - 1248, http://dx.doi.org/10.1111/dar.13194

McKETIN R; Quinn B; Higgs P; Berk M; Dean OM; Turner A; Kelly PJ; Lubman DI; Carter G; Baker AL; Manning V; Thomas T; Bathish R; Raftery D; Saunders L; Wrobel A; Meehan A; Sinclair B; Reid D; Arunogiri S; Hill H; Cordaro F; Dietze PM, 2021, 'Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial', Drug and Alcohol Review, 40, pp. 1249 - 1255, http://dx.doi.org/10.1111/dar.13183

Raftery D; Kelly PJ; Deane FP; Carter G; Dean OM; Lubman DI; Turner A; McKetin R, 2021, 'Cognitive insight, medication adherence and methamphetamine cessation in people enrolled in a pharmacotherapy trial for methamphetamine use', Journal of Substance Abuse Treatment, 130, http://dx.doi.org/10.1016/j.jsat.2021.108473

McKetin R; Sutherland R; Peacock A; Farrell M; Degenhardt L, 2021, 'Patterns of smoking and injecting methamphetamine and their association with health and social outcomes', Drug and Alcohol Review, 40, pp. 1256 - 1265, http://dx.doi.org/10.1111/dar.13364

McKetin R; Chrzanowska A; Man N; Peacock A; Sutherland R; Degenhardt L, 2021, 'Trends in treatment episodes for methamphetamine smoking and injecting in Australia, 2003–2019', Drug and Alcohol Review, 40, pp. 1281 - 1286, http://dx.doi.org/10.1111/dar.13258

McKetin R, 2021, 'Household surveys and the case of the Australian methamphetamine situation', Addiction, 116, pp. 2610 - 2611, http://dx.doi.org/10.1111/add.15480

McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Sinclair B; Reid D; Baker AL; Manning V; Pas NT; Thomas T; Bathish R; Raftery DK; Wrobel A; Saunders L; Arunogiri S; Cordaro F; Hill H; Hall S; Clare PJ; Mohebbi M; Berk M, 2021, 'N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial', eClinicalMedicine, 38, http://dx.doi.org/10.1016/j.eclinm.2021.101005

Hides L; Chan G; Dawe S; McKetin R; Kavanagh DJ; Young RMD; Teesson M; Saunders JB, 2021, 'Direction of the relationship between methamphetamine use and positive psychotic symptoms in regular methamphetamine users: Evidence from a prospective cohort study', British Journal of Psychiatry, 219, pp. 361 - 367, http://dx.doi.org/10.1192/bjp.2019.263

Voce A; Burns R; Castle D; Calabria B; McKetin R, 2021, 'A latent class analysis of psychiatric symptom profiles associated with past-month methamphetamine use', Psychiatry Research, 298, http://dx.doi.org/10.1016/j.psychres.2021.113760

McKetin R; Farrell M, 2021, 'When the evidence is not enough: is it time to rethink trial design?', Addiction, 116, pp. 711 - 712, http://dx.doi.org/10.1111/add.15273

Raftery D; Kelly PJ; Deane FP; Baker AL; Ingram I; Goh MCW; Lubman DI; Carter G; Turner A; Dean OM; Sinclair BL; McKetin R, 2020, 'Insight in substance use disorder: A systematic review of the literature', Addictive Behaviors, 111, http://dx.doi.org/10.1016/j.addbeh.2020.106549

McKetin R; Boden JM; Foulds JA; Najman JM; Ali R; Degenhardt L; Baker AL; Ross J; Farrell M; Weatherburn D, 2020, 'The contribution of methamphetamine use to crime: Evidence from Australian longitudinal data', Drug and Alcohol Dependence, 216, pp. 108262, http://dx.doi.org/10.1016/j.drugalcdep.2020.108262

Reilly R; Wand H; McKetin R; Quinn B; Ezard N; Dunlop A; Conigrave K; Treloar C; Roe Y; Gray D; Stephens J; Ward J, 2020, 'Survey methods and characteristics of a sample of Aboriginal and Torres Strait Islander and non-Indigenous people who have recently used methamphetamine: the NIMAC survey', Drug and Alcohol Review, 39, pp. 646 - 655, http://dx.doi.org/10.1111/dar.13085

McKetin R; Voce A; Burns RA; Quinn B, 2020, 'The Short Barriers Questionnaire (SBQ): Validity, factor structure and correlates in an out-of-treatment sample of people dependent on methamphetamine', Journal of Substance Abuse Treatment, 116, http://dx.doi.org/10.1016/j.jsat.2020.108029

Cumming C; Kinner SA; McKetin R; Li I; Preen D, 2020, 'Methamphetamine use, health and criminal justice system outcomes: A systematic review', Drug and Alcohol Review, 39, pp. 505 - 518, http://dx.doi.org/10.1111/dar.13062

Bórquez A; Rich K; Farrell M; Degenhardt L; McKetin R; Tran LT; Cepeda J; Silva-Santisteban A; Konda K; Cáceres CF; Kelly S; Altice FL; Martin NK, 2020, 'Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study', Journal of the International AIDS Society, 23, http://dx.doi.org/10.1002/jia2.25495

Kelly PJ; Baker AL; Fagan NL; Turner A; Deane F; McKetin R; Callister R; Collins C; Ingram I; Wolstencroft K; Townsend C; Osborne BA; Zimmermann A, 2020, 'Better Health Choices: Feasability and preliminary effectiveness of a peer delivered healthy lifestyle intervention in a community mental health setting', Addictive Behaviors, 103, http://dx.doi.org/10.1016/j.addbeh.2019.106249

Arunogiri S; McKetin R, 2020, 'Comment on Zang et al 2019: The importance of distinguishing between psychotic and general psychiatric symptoms in the context of methamphetamine use', Addiction Biology, 25, http://dx.doi.org/10.1111/adb.12776

Foulds JA; Boden JM; McKetin R; Newton-Howes G, 2020, 'Methamphetamine use and violence: Findings from a longitudinal birth cohort', Drug and Alcohol Dependence, 207, http://dx.doi.org/10.1016/j.drugalcdep.2019.107826

Arunogiri S; McKetin R; Verdejo-Garcia A; Lubman DI, 2020, 'The Methamphetamine-Associated Psychosis Spectrum: a Clinically Focused Review', International Journal of Mental Health and Addiction, 18, pp. 54 - 65, http://dx.doi.org/10.1007/s11469-018-9934-4

Arunogiri S; Verdejo-Garcia A; McKetin R; Rubenis AJ; Fitzpatrick RE; Lubman DI, 2019, 'Emotion Recognition and Impulsive Choice in Relation to Methamphetamine Use and Psychosis Symptoms', Frontiers in Psychiatry, 10, http://dx.doi.org/10.3389/fpsyt.2019.00889

Farrell M; Martin NK; Stockings E; Bórquez A; Cepeda JA; Degenhardt L; Ali R; Tran LT; Rehm J; Torrens M; Shoptaw S; McKetin R, 2019, 'Responding to global stimulant use: challenges and opportunities', The Lancet, 394, pp. 1652 - 1667, http://dx.doi.org/10.1016/S0140-6736(19)32230-5

McKetin R; Leung J; Stockings E; Huo Y; Foulds J; Lappin JM; Cumming C; Arunogiri S; Young JT; Sara G; Farrell M; Degenhardt L, 2019, 'Mental health outcomes associated with of the use of amphetamines: A systematic review and meta-analysis', EClinicalMedicine, 16, pp. 81 - 97, http://dx.doi.org/10.1016/j.eclinm.2019.09.014

Raftery D; Kelly PJ; Deane FP; Mcketin R; Baker AL; Turner A; Dean OM, 2019, 'Measuring cognitive insight in people with problematic substance use: An exploration of the factor validity of the Beck Cognitive Insight Scale', Drug and Alcohol Review, 38, pp. 622 - 629, http://dx.doi.org/10.1111/dar.12966

Voce A; Burns R; Castle D; Calabria B; McKetin R, 2019, 'Is there a discrete negative symptom syndrome in people who use methamphetamine?', Comprehensive Psychiatry, 93, pp. 27 - 32, http://dx.doi.org/10.1016/j.comppsych.2019.06.002

McKetin R; Voce A; Burns R; Shanahan M, 2019, 'Health-related quality of life among people who use methamphetamine', Drug and Alcohol Review, 38, pp. 503 - 509, http://dx.doi.org/10.1111/dar.12934

McKetin R; Dean OM; Turner A; Kelly PJ; Quinn B; Lubman DI; Dietze P; Carter G; Higgs P; Baker AL; Sinclair B; Reid D; Manning V; Te Pas N; Liang W; Thomas T; Bathish R; Kent M; Raftery D; Arunogiri S; Cordaro F; Hill H; Berk M, 2019, 'A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence', Trials, 20, http://dx.doi.org/10.1186/s13063-019-3450-0

Voce A; Calabria B; Burns R; Castle D; McKetin R, 2019, 'A Systematic Review of the Symptom Profile and Course of Methamphetamine-Associated Psychosis: Substance Use and Misuse', Substance Use and Misuse, 54, pp. 549 - 559, http://dx.doi.org/10.1080/10826084.2018.1521430

Reilly R; McKetin R; Wand H; Butt J; Smout M; Ezard N; Conigrave K; Clark Y; Quinn B; Treloar C; Gray D; Dunlop A; Roe Y; Ward J, 2019, 'A web-based therapeutic program (We Can Do This) for reducing methamphetamine use and increasing help-seeking among aboriginal and torres strait islander people: Protocol for a randomized wait-list controlled trial', Journal of Medical Internet Research, 21, http://dx.doi.org/10.2196/14084

Tait RJ; Whetton S; Shanahan M; Cartwright K; Ferrante A; Gray D; Kaye S; McKetin R; Pidd K; Ritter A; Roche A; Allsop S, 2018, 'Quantifying the societal cost of methamphetamine use to Australia', International Journal of Drug Policy, 62, pp. 30 - 36, http://dx.doi.org/10.1016/j.drugpo.2018.08.015

McKetin R; Voce A; Burns R; Ali R; Lubman DI; Baker AL; Castle DJ, 2018, 'Latent Psychotic Symptom Profiles Amongst People Who Use Methamphetamine: What Do They Tell Us About Existing Diagnostic Categories?', Frontiers in Psychiatry, 9, http://dx.doi.org/10.3389/fpsyt.2018.00578

McKetin R; Hides L; Kavanagh DJ; Saunders JB; Dawe S, 2018, 'First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine', Schizophrenia Research, 199, pp. 456 - 457, http://dx.doi.org/10.1016/j.schres.2018.04.021

McKetin R, 2018, 'Methamphetamine psychosis: insights from the past', Addiction, 113, pp. 1522 - 1527, http://dx.doi.org/10.1111/add.14170

Ezard N; Dunlop A; Hall M; Ali R; McKetin R; Bruno R; Phung N; Carr A; White J; Clifford B; Liu Z; Shanahan M; Dolan K; Baker AL; Lintzeris N, 2018, 'LiMA: A study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence', BMJ Open, 8, http://dx.doi.org/10.1136/bmjopen-2017-020723

Voce A; McKetin R; Burns R; Castle D; Calabria B, 2018, 'The relationship between illicit amphetamine use and psychiatric symptom profiles in schizophrenia and affective psychoses', Psychiatry Research, 265, pp. 19 - 24, http://dx.doi.org/10.1016/j.psychres.2018.04.015

McKetin R; Lubman DI; Baker A; Dawe S; Ross J; Mattick RP; Degenhardt L, 2018, 'The relationship between methamphetamine use and heterosexual behaviour: evidence from a prospective longitudinal study', Addiction, 113, pp. 1276 - 1285, http://dx.doi.org/10.1111/add.14181

Arunogiri S; Foulds JA; McKetin R; Lubman DI, 2018, 'A systematic review of risk factors for methamphetamine-associated psychosis', Australian and New Zealand Journal of Psychiatry, 52, pp. 514 - 529, http://dx.doi.org/10.1177/0004867417748750

McKetin R; Degenhardt L; Shanahan M; Baker AL; Lee NK; Lubman DI, 2018, 'Health service utilisation attributable to methamphetamine use in Australia: Patterns, predictors and national impact', Drug and Alcohol Review, 37, pp. 196 - 204, http://dx.doi.org/10.1111/dar.12518

Howard KA; Griffiths KM; McKetin R; Ma J, 2018, 'Can a brief biologically-based psychoeducational intervention reduce stigma and increase help-seeking intentions for depression in young people? A randomised controlled trial', Journal of Child and Adolescent Mental Health, 30, pp. 27 - 39, http://dx.doi.org/10.2989/17280583.2018.1467323

McKetin R; Kothe A; Baker AL; Lee NK; Ross J; Lubman DI, 2018, 'Predicting abstinence from methamphetamine use after residential rehabilitation: Findings from the Methamphetamine Treatment Evaluation Study', Drug and Alcohol Review, 37, pp. 70 - 78, http://dx.doi.org/10.1111/dar.12528

McKetin R, 2017, 'Why methamphetamine-related deaths need more attention', Addiction, 112, pp. 2203 - 2204, http://dx.doi.org/10.1111/add.14021

Kelly PJ; Robinson LD; Baker AL; Deane FP; McKetin R; Hudson S; Keane C, 2017, 'Polysubstance use in treatment seekers who inject amphetamine: Drug use profiles, injecting practices and quality of life', Addictive Behaviors, 71, pp. 25 - 30, http://dx.doi.org/10.1016/j.addbeh.2017.02.006

Room R; Dietze P; McKetin R, 2017, 'Gearing up at the Review', Drug and Alcohol Review, 36, pp. 441, http://dx.doi.org/10.1111/dar.12577

McKetin R; Baker AL; Dawe S; Voce A; Lubman DI, 2017, 'Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders', Psychiatry Research, 251, pp. 349 - 354, http://dx.doi.org/10.1016/j.psychres.2017.02.028

McKetin R; Allsop S, 2017, 'When the Evidence is not Enough: Commentary on Härtel-Petri et al', Pharmacopsychiatry, 50, pp. 105 - 106, http://dx.doi.org/10.1055/s-0043-102184

McKetin R; Dean OM; Baker AL; Carter G; Turner A; Kelly PJ; Berk M, 2017, 'A potential role for N-acetylcysteine in the management of methamphetamine dependence', Drug and Alcohol Review, 36, pp. 153 - 159, http://dx.doi.org/10.1111/dar.12414

Degenhardt L; Sara G; McKetin R; Roxburgh A; Dobbins T; Farrell M; Burns L; Hall WD, 2017, 'Crystalline methamphetamine use and methamphetamine-related harms in Australia', Drug and Alcohol Review, 36, pp. 160 - 170, http://dx.doi.org/10.1111/dar.12426

McKetin R; Parasu P; Cherbuin N; Eramudugolla R; Anstey KJ, 2016, 'A longitudinal examination of the relationship between cannabis use and cognitive function in mid-life adults', Drug and Alcohol Dependence, 169, pp. 134 - 140, http://dx.doi.org/10.1016/j.drugalcdep.2016.10.022

Back to profile page